105 related articles for article (PubMed ID: 8853563)
1. Detection of heparin-like glycosaminoglycans in normal human plasma by polyacrylamide-gel electrophoresis.
Cavari S; Vannucchi S
Clin Chim Acta; 1996 Aug; 252(2):159-70. PubMed ID: 8853563
[TBL] [Abstract][Full Text] [Related]
2. Heparin binding peptides co-purify with glycosaminoglycans from human plasma.
Chevanne M; Caldini R; Manao G; Ruggiero M; Vannucchi S
FEBS Lett; 1999 Dec; 463(1-2):121-4. PubMed ID: 10601650
[TBL] [Abstract][Full Text] [Related]
3. Isolation of endogenous anticoagulant N-sulfated glycosaminoglycans in human plasma from healthy subjects.
Ruggiero M; Melli M; Parma B; Bianchini P; Vannucchi S
Pathophysiol Haemost Thromb; 2002; 32(1):44-9. PubMed ID: 12214163
[TBL] [Abstract][Full Text] [Related]
4. A heparin-like anticoagulant as part of global abnormalities of plasma glycosaminoglycans in a patient with transitional cell carcinoma.
Horne MK; Chao ES; Wilson OJ; Scialla SJ; Lynch MA; Kragel PJ
J Lab Clin Med; 1991 Sep; 118(3):250-60. PubMed ID: 1919298
[TBL] [Abstract][Full Text] [Related]
5. Electrophoresis of glycosaminoglycans isolated from normal human plasma. Direct evidence for the presence of a heparin-like molecule.
Snow AD; Kisilevsky R; Stephens C; Anastassiades T
Biomed Biochim Acta; 1987; 46(7):537-46. PubMed ID: 3426567
[TBL] [Abstract][Full Text] [Related]
6. Proteolysis of human plasma reveals the presence of complexes formed by endogenous heparin and peptides that stimulate angiogenesis.
Pacini S; Ruggiero M; Cecchi F; Peruzzi B; Vannucchi S
Oncol Res; 2004; 14(10):501-11. PubMed ID: 15559764
[TBL] [Abstract][Full Text] [Related]
7. Improved method for analysis of glycosaminoglycans in glycosaminoglycan/protein mixtures: application in Cohn-Oncley fractions of human plasma.
Cecchi F; Ruggiero M; Cappelletti R; Lanini F; Vannucchi S
Clin Chim Acta; 2007 Feb; 376(1-2):142-9. PubMed ID: 16999947
[TBL] [Abstract][Full Text] [Related]
8. Electrophoresis and detection of nanogram quantities of exogenous and endogenous glycosaminoglycans in biological fluids.
al-Hakim A; Linhardt RJ
Appl Theor Electrophor; 1991; 1(6):305-12. PubMed ID: 1718441
[TBL] [Abstract][Full Text] [Related]
9. The effect of the beta-D-xyloside naroparcil on circulating plasma glycosaminoglycans. An explanation for its known antithrombotic activity in the rabbit.
Masson PJ; Coup D; Millet J; Brown NL
J Biol Chem; 1995 Feb; 270(6):2662-8. PubMed ID: 7852334
[TBL] [Abstract][Full Text] [Related]
10. The interaction of platelet factor four and glycosaminoglycans.
Loscalzo J; Melnick B; Handin RI
Arch Biochem Biophys; 1985 Jul; 240(1):446-55. PubMed ID: 2409923
[TBL] [Abstract][Full Text] [Related]
11. Heparin/heparan sulfate anticoagulant glycosaminoglycans in human plasma of healthy donors: preliminary study on a small group of recruits.
Cecchi F; Pacini S; Gulisano M; Macchi C; Catini C; Lova RM; Fuzzi G; Ruggiero M; Vannucchi S
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):349-54. PubMed ID: 18600081
[TBL] [Abstract][Full Text] [Related]
12. Interaction between endogenous circulating sulfated-glycosaminoglycans and plasma proteins.
Pasquali F; Oldani C; Ruggiero M; Magnelli L; Chiarugi V; Vannucchi S
Clin Chim Acta; 1990 Nov; 192(1):19-27. PubMed ID: 2261693
[TBL] [Abstract][Full Text] [Related]
13. Micromethod for the determination of heparin in plasma after intravenous and subcutaneous administration.
Oreste P; Peruzzi M; Stella P
Anal Biochem; 1993 Apr; 210(1):136-9. PubMed ID: 8489009
[TBL] [Abstract][Full Text] [Related]
14. Glycosaminoglycan analysis in brain stems from animals infected with the bovine spongiform encephalopathy agent.
Papakonstantinou E; Karakiulakis G; Roth M; Verghese-Nikolakaki S; Dawson M; Papadopoulos O; Sklaviadis T
Arch Biochem Biophys; 1999 Oct; 370(2):250-7. PubMed ID: 10510284
[TBL] [Abstract][Full Text] [Related]
15. Fractionation of heparin-derived oligosaccharides by gradient polyacrylamide-gel electrophoresis.
Rice KG; Rottink MK; Linhardt RJ
Biochem J; 1987 Jun; 244(3):515-22. PubMed ID: 3446173
[TBL] [Abstract][Full Text] [Related]
16. Endogenous heparinase-sensitive anticoagulant activity in human plasma.
Cavari S; Stramaccia L; Vannucchi S
Thromb Res; 1992 Jul; 67(2):157-65. PubMed ID: 1440519
[TBL] [Abstract][Full Text] [Related]
17. A method for separation of heparin species from biological samples by ethanol precipitation of compounds solubilized in guanidine hydrochloride.
Ruggiero M; Caldini R; Chevanne M; Melli M; Pacini S; Gulisano M; Vannucchi S
Ital J Anat Embryol; 2001; 106(1):35-46. PubMed ID: 11410997
[TBL] [Abstract][Full Text] [Related]
18. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
[TBL] [Abstract][Full Text] [Related]
19. Fractionation of heparin, dermatan sulfate, and chondroitin sulfate by sequential precipitation: a method to purify a single glycosaminoglycan species from a mixture.
Volpi N
Anal Biochem; 1994 May; 218(2):382-91. PubMed ID: 8074297
[TBL] [Abstract][Full Text] [Related]
20. Endogenous Glycosaminoglycans in Various Pathologic Plasma Samples as Measured by a Fluorescent Quenching Method.
Kantarcioglu B; Mehrotra S; Papineni C; Siddiqui F; Kouta A; Hoppensteadt D; Bansal V; Darki A; Van Thiel DH; Fareed J
Clin Appl Thromb Hemost; 2022; 28():10760296221144047. PubMed ID: 36474353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
